# Nysa Membrane Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nysa-membrane-technologies

- Industry: Biopolymers
- Headquarters: Burlington, Canada
- Website: www.nysamembranes.com
- Total disclosed funding: $2M
- Latest round: Series B (Oct 5, 2007)
- Investors on record: 5

## About

Nysa Membrane Technologies Inc. is a company focused on developing innovative membrane filtration technologies for water treatment and industrial processes, enhancing efficiency and sustainability in various applications.Nysa Membrane Technologies Inc. specializes in advanced membrane solutions for filtration applications. The company was acquired by MilliporeSigma, the life science business of Merck KGaA, in August 2017. Its headquarters is located in Burlington, Canada. The company has successfully closed three funding deals, with the most recent being a Series A round in which they raised USD 2.000 mn from Business Development Bank of Canada, Emerging Technology Partners, and Golden Horseshoe Life Sciences, totaling USD 2.000 mn raised.Nysa Membrane Technologies Inc. provides advanced membrane filtration solutions tailored for water treatment and various industrial processes. Their product offerings include innovative membrane technologies capable of efficiently filtering contaminants, thereby ensuring cleaner water and improving operational efficiency in industrial applications.Nysa Membrane Technologies Inc. generates revenue primarily through sales of its specialized membrane products, focusing on direct sales to businesses engaged in water treatment and industrial operations. Revenue is driven by B2B transactions, with pricing models adjusted based on volume, and long-term contracts with clients bolstering a steady revenue stream.Nysa Membrane Technologies Inc. aims to expand its product line with new membrane technologies expected to launch in the coming years. The company is targeting growth into new geographic markets, specifically in North America and Europe, by 2025. The recent acquisition by MilliporeSigma will support these initiatives by leveraging their resources and network to enhance product development and market reach.

## Funding rounds

- Series B, Oct 5, 2007 — BDC Capital, Jove Investment Management
- Series A, Sep 26, 2005, $2M — Emerging Technology Partners, Business Development Bank of Canada, Golden Horseshoe Life Sciences

## Investors

- Emerging Technology Partners (https://capitalatlas.ai/funds/emerging-technology-partners) — Series A
- Business Development Bank of Canada — Series A
- Golden Horseshoe Life Sciences — Series A
- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Series B
- Jove Investment Management — Series B